LumineticsCore is an Al diagnostic system that autonomously diagnoses diabetic retinopathy (including macular edema) in people living with diabetes.
Diagnostic results at the point-of-care
No need for specialist overread or telemedicine call backs
A simple user interface
Customized workflow integration solutions
The Problem: Every Year, Over 60,000 People Go Blind from Diabetic Retinopathy
How LumineticsCore Works
1 Using a fundus camera, the trained operator captures two images per eye
2 The images are submitted to LumineticsCore
3 LumineticsCore analyzes images for signs of diabetic retinopathy (including macular edema), providing results in less than a minute
Results
No diabetic retinopathy detected: Retest in 12 Months
Results
Diabetic retinopathy detected: Refer to an eye care professional
Our Approach to AI Driven Diagnostics
AI the Right Way™
LumineticsCore™ is modeled to look for and make decisions based on the same clinical disease detectors that eye care specialists would use.
Diagnostic AI built on an ethical foundation
Diagnostic results at the point-of-care
Infinitely scalable
High Performance in a
Real-World Clinical Setting
Safety
LumineticsCore was validated against patient outcomes using a surrogate outcome standard to keep patient safety the main priority.
Effective
In our pivotal clinical trial, LumineticsCore avoided 91% of unnecessary specialty visits by providing a diagnostic result that is negative for diabetic retinopathy (including macular edema) at the point-of-care.